8364. doi rational use of antibiotic is the key approach to improve the antibiotic performance and tackling of the antimicrobial resistance.

210 456-466. doi adams k. n. takaki k. connolly l. e. wiedenhoft h. winglee k. humbert o. et al.

cell 145 39-53. doi akiyama h. ueda m. kanzaki h. tada j. and arata j.

16 2-10. doi amato s. m. orman m. a. and brynildsen m. p. 2013. metabolic control of persister formation in escherichia coli.

cell 50 475-487. doi andersson d. i. and hughes d. 2014. microbiological effects of sublethal levels of antibiotics.

12 465-478. doi bae j. oh e. and jeon b.

58 7573-7575. doi baharoglu z. and mazel d. 2011. vibrio cholerae triggers sos and mutagenesis in response to a wide range of antibiotics a route towards multiresistance.

55 2438-2441. doi balaban n. q. merrin j. chait r. kowalik l. and leibler s. 2004. bacterial persistence as a phenotypic switch.

science 305 1622-1625. doi baquero f. 2001. low-level antibacterial resistance a gateway to clinical resistance.

4 93-105. doi baquero f. negri m. c. morosini m. i. and blazquez j.

doi beaber j. w. hochhut b. and waldor m. k. 2004. sos response promotes horizontal dissemination of antibiotic resistance genes.

nature 427 72-74. doi becattini s. taur y. and pamer e. g. 2016. antibiotic-induced changes in the intestinal microbiota and disease.

22 458-478. doi beer j. wagner c. c. and zeitlinger m. 2009. protein binding of antimicrobials methods for quantification and for investigation of its impact on bacterial killing.

11 1-12. doi bergogne-berezin e. 2002. clinical role of protein binding of quinolones.

41 741-750. doi bernier s. p. lebeaux d. defrancesco a. s. valomon a. soubigou g. coppeej.

